84
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Oralair®: sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis

&
Pages 437-444 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emmanuel Nony, Armelle Martelet, Karine Jain & Philippe Moingeon. (2016) Allergen extracts for immunotherapy: to mix or not to mix?. Expert Review of Clinical Pharmacology 9:3, pages 401-408.
Read now
Alain Didier, Ulrich Wahn, Friedrich Horak & Linda S Cox. (2014) Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience. Expert Review of Clinical Immunology 10:10, pages 1309-1324.
Read now

Articles from other publishers (5)

S. Aissa, R. Ben Jazia, J. Ayachi, C. Ben Salem, A. Hayouni, A. Abdelghani, H. Ben Saad & M. Boussarsar. (2016) Critical appraisal of the clinical utility of sublingual immunotherapy in allergy. Contemporary Clinical Trials Communications 4, pages 1-8.
Crossref
Jørgen Nedergaard Larsen, Louise Broge & Henrik Jacobi. (2016) Allergy immunotherapy: the future of allergy treatment. Drug Discovery Today 21:1, pages 26-37.
Crossref
Kristian Aasbjerg, Kim Peder Dalhoff & Vibeke Backer. (2015) Adverse Events During Immunotherapy Against Grass Pollen-Induced Allergic Rhinitis - Differences Between Subcutaneous and Sublingual Treatment. Basic & Clinical Pharmacology & Toxicology 117:2, pages 73-84.
Crossref
Jenny K.W. Lam, Yingying Xu, Alan Worsley & Ian C.K. Wong. (2014) Oral transmucosal drug delivery for pediatric use. Advanced Drug Delivery Reviews 73, pages 50-62.
Crossref
Cristoforo IncorvaiaNicola Fuiano & Franco Frati. (2012) Allergen immunotherapy: how to balance the different views from pulmonologists and allergists?. Immunotherapy 4:8, pages 853-857.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.